• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Untangling Lower Airway Dysbiosis in Critically Ill Patients with COVID-19.

作者信息

Barnett Clea R, Segal Leopoldo N

机构信息

Division of Pulmonary and Critical Care Medicine New York University Grossman School of Medicine New York, New York.

出版信息

Am J Respir Crit Care Med. 2022 Oct 1;206(7):806-808. doi: 10.1164/rccm.202206-1074ED.

DOI:10.1164/rccm.202206-1074ED
PMID:35696343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9799272/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0b/9799272/c280d70c3a2e/rccm.202206-1074EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0b/9799272/c280d70c3a2e/rccm.202206-1074EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0b/9799272/c280d70c3a2e/rccm.202206-1074EDf1.jpg

相似文献

1
Untangling Lower Airway Dysbiosis in Critically Ill Patients with COVID-19.解析新冠重症患者下呼吸道微生物群失调
Am J Respir Crit Care Med. 2022 Oct 1;206(7):806-808. doi: 10.1164/rccm.202206-1074ED.
2
The lower respiratory tract microbiome of critically ill patients with COVID-19.COVID-19 危重症患者的下呼吸道微生物组。
Sci Rep. 2021 May 12;11(1):10103. doi: 10.1038/s41598-021-89516-6.
3
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.COVID-19 重症患者表现出肺部真菌失调，定植有 Candida spp. 的患者微生物多样性减少。
Int J Infect Dis. 2022 Apr;117:233-240. doi: 10.1016/j.ijid.2022.02.011. Epub 2022 Feb 9.
4
COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.新型冠状病毒肺炎影响肺部微生物群动态变化并促使罕见传染病的出现：一例蜂房哈夫尼亚菌肺炎病例报告
J Crit Care. 2021 Aug;64:173-175. doi: 10.1016/j.jcrc.2021.04.008. Epub 2021 Apr 18.
5
Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients.呼吸道微生态失调与机械通气患者的预后不良有关。
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1666-1677. doi: 10.1164/rccm.201912-2441OC.
6
Microbiome in Critical Care: An Unconventional and Unknown Ally.重症监护中的微生物组：一个非常规且未知的盟友。
Curr Med Chem. 2022;29(18):3179-3188. doi: 10.2174/0929867328666210915115056.
7
Gut microbiota and host defense in critical illness.肠道微生物群与危重病中的宿主防御
Curr Opin Crit Care. 2017 Aug;23(4):257-263. doi: 10.1097/MCC.0000000000000424.
8
[Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients].危重症患者肠道微生物群及以微生物群为靶点的治疗研究进展
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1099-1102. doi: 10.3760/cma.j.issn.2095-4352.2018.011.018.
9
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.围生期组织来源的间充质干细胞治疗危重症 COVID-19 诱导的 ARDS 患者：病例系列。
Stem Cell Res Ther. 2021 Jan 29;12(1):91. doi: 10.1186/s13287-021-02165-4.
10
Renin-angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report.新型冠状病毒肺炎所致急性呼吸窘迫综合征重症患者的肾素-血管紧张素系统失调：初步报告
Crit Care. 2021 Mar 1;25(1):91. doi: 10.1186/s13054-021-03507-7.

引用本文的文献

1
Lung microbiota composition, respiratory mechanics, and outcomes in COVID-19-related ARDS.COVID-19 相关 ARDS 患者的肺部微生物群落组成、呼吸力学和结局。
Microbiol Spectr. 2024 Apr 2;12(4):e0357423. doi: 10.1128/spectrum.03574-23. Epub 2024 Mar 11.
2
Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19.微生物负荷相关的细胞因子风暴可能解释新冠病毒疾病患者无法缓解的急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1182-1183. doi: 10.1164/rccm.202207-1266LE.

本文引用的文献

1
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.COVID-19 危重症患者的肺部微生物群与非解决性急性呼吸窘迫综合征相关。
Am J Respir Crit Care Med. 2022 Oct 1;206(7):846-856. doi: 10.1164/rccm.202202-0274OC.
2
Towards a biological definition of ARDS: are treatable traits the solution?迈向急性呼吸窘迫综合征的生物学定义：可治疗特征是解决之道吗？
Intensive Care Med Exp. 2022 Mar 11;10(1):8. doi: 10.1186/s40635-022-00435-w.
3
Lung microbiota and COVID-19 severity.肺部微生物群与新冠病毒疾病严重程度
Nat Microbiol. 2021 Oct;6(10):1217-1218. doi: 10.1038/s41564-021-00969-x.
4
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.机械通气 COVID-19 患者下呼吸道中的微生物特征与不良临床结局相关。
Nat Microbiol. 2021 Oct;6(10):1245-1258. doi: 10.1038/s41564-021-00961-5. Epub 2021 Aug 31.
5
A minimal common outcome measure set for COVID-19 clinical research.用于 COVID-19 临床研究的最小通用结局指标集。
Lancet Infect Dis. 2020 Aug;20(8):e192-e197. doi: 10.1016/S1473-3099(20)30483-7. Epub 2020 Jun 12.
6
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局：一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
7
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
10
American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection.美国支气管学与介入肺病学协会（AABIP）关于疑似或确诊新型冠状病毒肺炎（COVID-19）感染患者支气管镜检查及呼吸道标本采集应用的声明
J Bronchology Interv Pulmonol. 2020 Oct;27(4):e52-e54. doi: 10.1097/LBR.0000000000000681.